Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pinaki Biswas

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
American Journal of Clinical Dermatology|May 5, 2026
Itch Relief and Quality-of-Life Improvement with Abrocitinib and Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE COMPARE and JADE DAREGil Yosipovitch, Melinda J Gooderham, Sarina B Elmariah, et al.
American Journal of Clinical Dermatology|May 6, 2021
Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported OutcomesJonathan I Silverberg, Jacob P Thyssen, Eric L Simpson, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|June 27, 2021
Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy StudiesBrian S Kim, Jonathan I Silverberg, Sonja Ständer, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|September 1, 2005
Treatment of fibromyalgia with formula acupuncture: investigation of needle placement, needle stimulation, and treatment frequencyRichard E Harris, Xiaoming Tian, David A Williams, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 10, 2023
Abrocitinib efficacy and safety in moderate-to-severe atopic dermatitis by race, ethnicity, and Fitzpatrick skin typeAndrew F Alexis, Jonathan I Silverberg, Zakiya P Rice, et al.
Antimicrobial Agents and Chemotherapy|July 14, 2010
International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazoleOlivier Lortholary, Gaelle Obenga, Pinaki Biswas, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2017
The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II TrialKevin L Winthrop, Ann G Wouters, Ernest H Choy, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 15, 2018
Evaluation of the Short-, Mid-, and Long-Term Effects of Tofacitinib on Lymphocytes in Patients With Rheumatoid ArthritisRonald van Vollenhoven, Eun Bong Lee, Sander Strengholt, et al.
Dermatology (Basel, Switzerland)|December 11, 2023
Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic DermatitisJacob P Thyssen, Anthony Bewley, Sonja Ständer, et al.
Allergy|March 3, 2025
Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate-to-Severe Atopic DermatitisAmy S Paller, Lawrence F Eichenfield, Alan D Irvine, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
American Journal of Clinical Dermatology|May 5, 2026
Itch Relief and Quality-of-Life Improvement with Abrocitinib and Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE COMPARE and JADE DAREGil Yosipovitch, Melinda J Gooderham, Sarina B Elmariah, et al.
American Journal of Clinical Dermatology|May 6, 2021
Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported OutcomesJonathan I Silverberg, Jacob P Thyssen, Eric L Simpson, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|June 27, 2021
Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy StudiesBrian S Kim, Jonathan I Silverberg, Sonja Ständer, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|September 1, 2005
Treatment of fibromyalgia with formula acupuncture: investigation of needle placement, needle stimulation, and treatment frequencyRichard E Harris, Xiaoming Tian, David A Williams, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 10, 2023
Abrocitinib efficacy and safety in moderate-to-severe atopic dermatitis by race, ethnicity, and Fitzpatrick skin typeAndrew F Alexis, Jonathan I Silverberg, Zakiya P Rice, et al.
Antimicrobial Agents and Chemotherapy|July 14, 2010
International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazoleOlivier Lortholary, Gaelle Obenga, Pinaki Biswas, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2017
The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II TrialKevin L Winthrop, Ann G Wouters, Ernest H Choy, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 15, 2018
Evaluation of the Short-, Mid-, and Long-Term Effects of Tofacitinib on Lymphocytes in Patients With Rheumatoid ArthritisRonald van Vollenhoven, Eun Bong Lee, Sander Strengholt, et al.
Dermatology (Basel, Switzerland)|December 11, 2023
Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic DermatitisJacob P Thyssen, Anthony Bewley, Sonja Ständer, et al.
Allergy|March 3, 2025
Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate-to-Severe Atopic DermatitisAmy S Paller, Lawrence F Eichenfield, Alan D Irvine, et al.
Pageof 6